Medesis Pharma S.A.
Medesis Pharma S.A. ALMDP.PA Peers
See (ALMDP.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ALMDP.PA | $0.35 | N/A | 1.80M | -0.59 | -$0.59 | N/A |
| ARGX.BR | $516.40 | -1.03% | 31.53B | 35.39 | $14.59 | N/A |
| UCB.BR | $160.50 | -1.92% | 30.50B | 29.29 | $5.48 | +0.87% |
| TUB.BR | $125.80 | -1.41% | 5.60B | 61.97 | $2.03 | +0.83% |
| GLPG.AS | $25.42 | -1.85% | 1.68B | -9.31 | -$2.73 | N/A |
| PHARM.AS | $0.94 | -1.06% | 637.79M | -46.87 | -$0.02 | N/A |
| GTBP.PA | $280.50 | N/A | 626.73M | -4.10 | -$68.39 | N/A |
| MEDCL.PA | $15.85 | +0.76% | 524.14M | -14.54 | -$1.09 | N/A |
| VLA.PA | $2.83 | -0.91% | 473.36M | -5.06 | -$0.56 | N/A |
| IVA.PA | $2.80 | +0.72% | 398.93M | -0.91 | -$3.08 | N/A |
Stock Comparison
ALMDP.PA vs ARGX.BR Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ARGX.BR has a market cap of 31.53B. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ARGX.BR trades at $516.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ARGX.BR's P/E ratio is 35.39. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ARGX.BR's ROE of +0.17%. Regarding short-term risk, ALMDP.PA is more volatile compared to ARGX.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs UCB.BR Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, UCB.BR has a market cap of 30.50B. Regarding current trading prices, ALMDP.PA is priced at $0.35, while UCB.BR trades at $160.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas UCB.BR's P/E ratio is 29.29. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to UCB.BR's ROE of +0.11%. Regarding short-term risk, ALMDP.PA is more volatile compared to UCB.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs TUB.BR Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, TUB.BR has a market cap of 5.60B. Regarding current trading prices, ALMDP.PA is priced at $0.35, while TUB.BR trades at $125.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas TUB.BR's P/E ratio is 61.97. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to TUB.BR's ROE of +0.05%. Regarding short-term risk, ALMDP.PA is more volatile compared to TUB.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs GLPG.AS Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, GLPG.AS has a market cap of 1.68B. Regarding current trading prices, ALMDP.PA is priced at $0.35, while GLPG.AS trades at $25.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas GLPG.AS's P/E ratio is -9.31. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to GLPG.AS's ROE of -0.06%. Regarding short-term risk, ALMDP.PA is more volatile compared to GLPG.AS. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs PHARM.AS Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, PHARM.AS has a market cap of 637.79M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while PHARM.AS trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas PHARM.AS's P/E ratio is -46.87. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to PHARM.AS's ROE of -0.06%. Regarding short-term risk, ALMDP.PA is more volatile compared to PHARM.AS. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs GTBP.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, GTBP.PA has a market cap of 626.73M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while GTBP.PA trades at $280.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas GTBP.PA's P/E ratio is -4.10. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to GTBP.PA's ROE of -4.68%. Regarding short-term risk, ALMDP.PA is less volatile compared to GTBP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs MEDCL.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, MEDCL.PA has a market cap of 524.14M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while MEDCL.PA trades at $15.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas MEDCL.PA's P/E ratio is -14.54. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to MEDCL.PA's ROE of +0.66%. Regarding short-term risk, ALMDP.PA is more volatile compared to MEDCL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs VLA.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, VLA.PA has a market cap of 473.36M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while VLA.PA trades at $2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas VLA.PA's P/E ratio is -5.06. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to VLA.PA's ROE of -0.43%. Regarding short-term risk, ALMDP.PA is more volatile compared to VLA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs IVA.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, IVA.PA has a market cap of 398.93M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while IVA.PA trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas IVA.PA's P/E ratio is -0.91. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to IVA.PA's ROE of +1.98%. Regarding short-term risk, ALMDP.PA is more volatile compared to IVA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ABVX.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ABVX.PA has a market cap of 331.14M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ABVX.PA trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ABVX.PA's P/E ratio is -1.85. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ABVX.PA's ROE of -2.11%. Regarding short-term risk, ALMDP.PA is more volatile compared to ABVX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ORY.MC Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ORY.MC has a market cap of 212.29M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ORY.MC trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ORY.MC's P/E ratio is -39.14. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ORY.MC's ROE of -0.04%. Regarding short-term risk, ALMDP.PA is more volatile compared to ORY.MC. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs DBV.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, DBV.PA has a market cap of 211.37M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while DBV.PA trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas DBV.PA's P/E ratio is -1.53. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to DBV.PA's ROE of -2.68%. Regarding short-term risk, ALMDP.PA is more volatile compared to DBV.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs GNFT.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, GNFT.PA has a market cap of 201.84M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while GNFT.PA trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas GNFT.PA's P/E ratio is 135.13. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to GNFT.PA's ROE of +0.02%. Regarding short-term risk, ALMDP.PA is more volatile compared to GNFT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ONWD.BR Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ONWD.BR has a market cap of 184.61M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ONWD.BR trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ONWD.BR's P/E ratio is -5.17. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ONWD.BR's ROE of -1.08%. Regarding short-term risk, ALMDP.PA is more volatile compared to ONWD.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs IPH.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, IPH.PA has a market cap of 181.37M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while IPH.PA trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas IPH.PA's P/E ratio is -3.23. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to IPH.PA's ROE of -2.63%. Regarding short-term risk, ALMDP.PA is more volatile compared to IPH.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs HYL.BR Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, HYL.BR has a market cap of 167.44M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while HYL.BR trades at $5.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas HYL.BR's P/E ratio is -26.00. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to HYL.BR's ROE of -0.19%. Regarding short-term risk, ALMDP.PA is more volatile compared to HYL.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs NANO.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, NANO.PA has a market cap of 156.41M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while NANO.PA trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas NANO.PA's P/E ratio is -2.31. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to NANO.PA's ROE of +0.77%. Regarding short-term risk, ALMDP.PA is more volatile compared to NANO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs OSE.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, OSE.PA has a market cap of 141.87M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while OSE.PA trades at $6.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas OSE.PA's P/E ratio is 4.36. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to OSE.PA's ROE of +0.52%. Regarding short-term risk, ALMDP.PA is more volatile compared to OSE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALSEN.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALSEN.PA has a market cap of 99.16M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALSEN.PA trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALSEN.PA's P/E ratio is -3.67. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALSEN.PA's ROE of -0.33%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALSEN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALCLS.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALCLS.PA has a market cap of 96.32M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALCLS.PA trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALCLS.PA's P/E ratio is -2.26. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALCLS.PA's ROE of -0.29%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALCLS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs MAAT.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, MAAT.PA has a market cap of 82.83M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while MAAT.PA trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas MAAT.PA's P/E ratio is -2.34. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to MAAT.PA's ROE of -1.61%. Regarding short-term risk, ALMDP.PA is more volatile compared to MAAT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs TNG.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, TNG.PA has a market cap of 74.15M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while TNG.PA trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas TNG.PA's P/E ratio is -1.94. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to TNG.PA's ROE of -4.66%. Regarding short-term risk, ALMDP.PA is more volatile compared to TNG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ADOC.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ADOC.PA has a market cap of 67.17M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ADOC.PA trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ADOC.PA's P/E ratio is -3.72. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ADOC.PA's ROE of +1.28%. Regarding short-term risk, ALMDP.PA is more volatile compared to ADOC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ERYP.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ERYP.PA has a market cap of 48.66M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ERYP.PA trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ERYP.PA's P/E ratio is -80.10. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ERYP.PA's ROE of -0.73%. Regarding short-term risk, ALMDP.PA is more volatile compared to ERYP.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs VVY.AS Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, VVY.AS has a market cap of 45.98M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while VVY.AS trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas VVY.AS's P/E ratio is -2.23. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to VVY.AS's ROE of -1.88%. Regarding short-term risk, ALMDP.PA is more volatile compared to VVY.AS. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ABNX.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ABNX.PA has a market cap of 43.35M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ABNX.PA trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ABNX.PA's P/E ratio is -9.62. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ABNX.PA's ROE of -0.52%. Regarding short-term risk, ALMDP.PA is more volatile compared to ABNX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALGEN.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALGEN.PA has a market cap of 29.76M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALGEN.PA trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALGEN.PA's P/E ratio is 13.00. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALGEN.PA's ROE of +0.10%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALGEN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs COX.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, COX.PA has a market cap of 29.04M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while COX.PA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas COX.PA's P/E ratio is -0.46. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to COX.PA's ROE of -0.43%. Regarding short-term risk, ALMDP.PA is more volatile compared to COX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs SIGHT.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, SIGHT.PA has a market cap of 25.26M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while SIGHT.PA trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas SIGHT.PA's P/E ratio is -1.29. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to SIGHT.PA's ROE of +0.54%. Regarding short-term risk, ALMDP.PA is more volatile compared to SIGHT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs POXEL.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, POXEL.PA has a market cap of 24.52M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while POXEL.PA trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas POXEL.PA's P/E ratio is -1.14. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to POXEL.PA's ROE of +0.32%. Regarding short-term risk, ALMDP.PA is more volatile compared to POXEL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs FALG.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, FALG.PA has a market cap of 23.95M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while FALG.PA trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas FALG.PA's P/E ratio is -2.33. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to FALG.PA's ROE of -0.39%. Regarding short-term risk, ALMDP.PA is more volatile compared to FALG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs DMSIM.BR Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, DMSIM.BR has a market cap of 23.09M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while DMSIM.BR trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas DMSIM.BR's P/E ratio is 0.09. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to DMSIM.BR's ROE of -0.57%. Regarding short-term risk, ALMDP.PA is more volatile compared to DMSIM.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALDVI.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALDVI.PA has a market cap of 21.11M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALDVI.PA trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALDVI.PA's P/E ratio is -3.58. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALDVI.PA's ROE of +0.44%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALDVI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs CYAD.BR Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, CYAD.BR has a market cap of 18.89M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while CYAD.BR trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas CYAD.BR's P/E ratio is -0.34. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to CYAD.BR's ROE of +0.91%. Regarding short-term risk, ALMDP.PA is more volatile compared to CYAD.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs AELIS.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, AELIS.PA has a market cap of 16.79M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while AELIS.PA trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas AELIS.PA's P/E ratio is -2.23. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to AELIS.PA's ROE of -0.74%. Regarding short-term risk, ALMDP.PA is more volatile compared to AELIS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALVAL.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALVAL.PA has a market cap of 16.77M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALVAL.PA trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALVAL.PA's P/E ratio is -1.68. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALVAL.PA's ROE of -0.74%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALVAL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALNFL.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALNFL.PA has a market cap of 16.17M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALNFL.PA trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALNFL.PA's P/E ratio is -7.57. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALNFL.PA's ROE of -1.27%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALNFL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALPHE.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALPHE.PA has a market cap of 15.83M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALPHE.PA trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALPHE.PA's P/E ratio is -2.67. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALPHE.PA's ROE of -0.64%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALPHE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALPAT.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALPAT.PA has a market cap of 12.34M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALPAT.PA trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALPAT.PA's P/E ratio is 11.11. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALPAT.PA's ROE of +0.01%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALPAT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs BAI.AS Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, BAI.AS has a market cap of 11.25M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while BAI.AS trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas BAI.AS's P/E ratio is -0.13. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to BAI.AS's ROE of -0.51%. Regarding short-term risk, ALMDP.PA is less volatile compared to BAI.AS. This indicates potentially lower risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALVET.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALVET.PA has a market cap of 10.02M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALVET.PA trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALVET.PA's P/E ratio is -0.17. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALVET.PA's ROE of -0.32%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALVET.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALVIO.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALVIO.PA has a market cap of 10.01M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALVIO.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALVIO.PA's P/E ratio is -0.46. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALVIO.PA's ROE of -2.09%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALVIO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs APM.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, APM.PA has a market cap of 8.82M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while APM.PA trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas APM.PA's P/E ratio is -0.71. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to APM.PA's ROE of +0.08%. Regarding short-term risk, ALMDP.PA is less volatile compared to APM.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALTHX.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALTHX.PA has a market cap of 7.99M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALTHX.PA trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALTHX.PA's P/E ratio is -4.52. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALTHX.PA's ROE of +7.08%. Regarding short-term risk, ALMDP.PA is less volatile compared to ALTHX.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALTME.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALTME.PA has a market cap of 7.16M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALTME.PA trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALTME.PA's P/E ratio is -0.67. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALTME.PA's ROE of -8.99%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALTME.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALQGC.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALQGC.PA has a market cap of 5.00M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALQGC.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALQGC.PA's P/E ratio is -0.09. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALQGC.PA's ROE of +14.01%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALQGC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs LYS.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, LYS.PA has a market cap of 4.95M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while LYS.PA trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas LYS.PA's P/E ratio is -0.64. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to LYS.PA's ROE of -11.30%. Regarding short-term risk, ALMDP.PA is more volatile compared to LYS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALINT.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALINT.PA has a market cap of 4.19M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALINT.PA trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALINT.PA's P/E ratio is -15.85. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALINT.PA's ROE of -0.14%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALINT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALHYG.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALHYG.PA has a market cap of 3.95M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALHYG.PA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALHYG.PA's P/E ratio is -0.26. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALHYG.PA's ROE of -6.80%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALHYG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALACT.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALACT.PA has a market cap of 3.94M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALACT.PA trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALACT.PA's P/E ratio is -0.22. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALACT.PA's ROE of +1.38%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALACT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALBPS.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALBPS.PA has a market cap of 2.98M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALBPS.PA trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALBPS.PA's P/E ratio is -0.04. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALBPS.PA's ROE of +1.88%. Regarding short-term risk, ALMDP.PA is more volatile compared to ALBPS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs GNRO.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, GNRO.PA has a market cap of 2.34M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while GNRO.PA trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas GNRO.PA's P/E ratio is -0.13. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to GNRO.PA's ROE of +2.39%. Regarding short-term risk, ALMDP.PA is more volatile compared to GNRO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALDEI.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALDEI.PA has a market cap of 1.13M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALDEI.PA trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALDEI.PA's P/E ratio is -0.11. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALDEI.PA's ROE of +0.61%. Regarding short-term risk, ALMDP.PA is less volatile compared to ALDEI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs BIOS.BR Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, BIOS.BR has a market cap of 1.04M. Regarding current trading prices, ALMDP.PA is priced at $0.35, while BIOS.BR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas BIOS.BR's P/E ratio is -0.04. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to BIOS.BR's ROE of +0.34%. Regarding short-term risk, ALMDP.PA is more volatile compared to BIOS.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs OVXA.IR Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, OVXA.IR has a market cap of 856420.00. Regarding current trading prices, ALMDP.PA is priced at $0.35, while OVXA.IR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas OVXA.IR's P/E ratio is -0.21. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to OVXA.IR's ROE of -0.00%. Regarding short-term risk, ALMDP.PA is more volatile compared to OVXA.IR. This indicates potentially higher risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs OXUR.BR Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, OXUR.BR has a market cap of 339714.00. Regarding current trading prices, ALMDP.PA is priced at $0.35, while OXUR.BR trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas OXUR.BR's P/E ratio is N/A. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to OXUR.BR's ROE of -0.01%. Regarding short-term risk, ALMDP.PA is less volatile compared to OXUR.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALNEV.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALNEV.PA has a market cap of 9934.00. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALNEV.PA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALNEV.PA's P/E ratio is N/A. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALNEV.PA's ROE of -1.79%. Regarding short-term risk, ALMDP.PA is less volatile compared to ALNEV.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALMDP.PA.
ALMDP.PA vs ALPHA.PA Comparison
ALMDP.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALMDP.PA stands at 1.80M. In comparison, ALPHA.PA has a market cap of 1190.00. Regarding current trading prices, ALMDP.PA is priced at $0.35, while ALPHA.PA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALMDP.PA currently has a P/E ratio of -0.59, whereas ALPHA.PA's P/E ratio is -0.00. In terms of profitability, ALMDP.PA's ROE is +0.40%, compared to ALPHA.PA's ROE of +0.83%. Regarding short-term risk, ALMDP.PA is less volatile compared to ALPHA.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALMDP.PA.